Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.33−0.23 (-2.18%)
Close on Nov 17, 2026Market cap $181.76MP/E 10.2Yield –
Natures Sunshine Products total assets
Total assets on the balance sheet at the end of each period.
Natures Sunshine Products's total assets was $259.82M at Jun 30, 2026. For fiscal 2025 it was $261.15M, up 8.4% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $261.15M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $261.15M | +8.4% |
| FY2024 | Dec 31, 2024 | $240.86M | -3.6% |
| FY2023 | Dec 31, 2023 | $249.77M | +8.7% |
| FY2022 | Dec 31, 2022 | $229.78M | -11.2% |
| FY2021 | Dec 31, 2021 | $258.87M | +3.8% |
| FY2020 | Dec 31, 2020 | $249.50M | +17.1% |
| FY2019 | Dec 31, 2019 | $213.07M | +10.4% |
| FY2018 | Dec 31, 2018 | $193.02M | -1.1% |
| FY2017 | Dec 31, 2017 | $195.20M | -5.0% |
| FY2016 | Dec 31, 2016 | $205.57M | +2.5% |
| FY2015 | Dec 31, 2015 | $200.52M | +1.9% |
| FY2014 | Dec 31, 2014 | $196.80M | -1.4% |
| FY2013 | Dec 31, 2013 | $199.61M | +2.9% |
| FY2012 | Dec 31, 2012 | $193.92M | +10.3% |
| FY2011 | Dec 31, 2011 | $175.81M | +10.3% |
| FY2010 | Dec 31, 2010 | $159.42M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $259.82M | +1.9% |
| Q1 FY2026 | Mar 31, 2026 | $261.46M | +3.5% |
| Q4 FY2025 | Dec 31, 2025 | $261.15M | +8.4% |
| Q3 FY2025 | Sep 30, 2025 | $264.81M | +7.9% |
| Q2 FY2025 | Jun 30, 2025 | $254.88M | +8.1% |
| Q1 FY2025 | Mar 31, 2025 | $252.70M | +2.2% |
| Q4 FY2024 | Dec 31, 2024 | $240.86M | -3.6% |
| Q3 FY2024 | Sep 30, 2024 | $245.33M | +2.3% |
| Q2 FY2024 | Jun 30, 2024 | $235.83M | -0.1% |
| Q1 FY2024 | Mar 31, 2024 | $247.27M | +5.4% |
| Q4 FY2023 | Dec 31, 2023 | $249.77M | +8.7% |
| Q3 FY2023 | Sep 30, 2023 | $239.91M | +7.3% |
| Q2 FY2023 | Jun 30, 2023 | $236.15M | +1.3% |
| Q1 FY2023 | Mar 31, 2023 | $234.58M | -1.7% |
| Q4 FY2022 | Dec 31, 2022 | $229.78M | -11.2% |
| Q3 FY2022 | Sep 30, 2022 | $223.51M | -6.8% |
| Q2 FY2022 | Jun 30, 2022 | $233.06M | -0.1% |
| Q1 FY2022 | Mar 31, 2022 | $238.66M | -2.9% |
| Q4 FY2021 | Dec 31, 2021 | $258.87M | +3.8% |
| Q3 FY2021 | Sep 30, 2021 | $239.75M | +1.0% |
| Q2 FY2021 | Jun 30, 2021 | $233.19M | +2.8% |
| Q1 FY2021 | Mar 31, 2021 | $245.83M | +14.1% |
| Q4 FY2020 | Dec 31, 2020 | $249.50M | +17.1% |
| Q3 FY2020 | Sep 30, 2020 | $237.42M | +10.6% |
| Q2 FY2020 | Jun 30, 2020 | $226.93M | +4.9% |
| Q1 FY2020 | Mar 31, 2020 | $215.44M | +3.2% |
| Q4 FY2019 | Dec 31, 2019 | $213.07M | +10.4% |
| Q3 FY2019 | Sep 30, 2019 | $214.75M | +12.1% |
| Q2 FY2019 | Jun 30, 2019 | $216.25M | +11.2% |
| Q1 FY2019 | Mar 31, 2019 | $208.78M | +9.0% |
| Q4 FY2018 | Dec 31, 2018 | $193.02M | -1.1% |
| Q3 FY2018 | Sep 30, 2018 | $191.53M | -13.8% |
| Q2 FY2018 | Jun 30, 2018 | $194.46M | -6.8% |
| Q1 FY2018 | Mar 31, 2018 | $191.55M | -9.1% |
| Q4 FY2017 | Dec 31, 2017 | $195.20M | -5.0% |
| Q3 FY2017 | Sep 30, 2017 | $222.21M | +3.4% |
| Q2 FY2017 | Jun 30, 2017 | $208.56M | – |
| Q1 FY2017 | Mar 31, 2017 | $210.74M | – |
| Q4 FY2016 | Dec 31, 2016 | $205.57M | – |
| Q3 FY2016 | Sep 30, 2016 | $214.90M | – |
See a number that looks wrong?